We are live on
!
Find out more
VIA
Vident Investment Advisory Portfolio holdings
AUM
$2.9B
1-Year Est. Return
24.67%
This Fund
S&P 500
This Quarter
Est. Return
-0.3%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
–
AUM
$752M
AUM Growth
+$253M
(+51%)
Cap. Flow
+$268M
Cap. Flow
% of AUM
35.64%
Top 10 Holdings %
Top 10 Hldgs %
9.6%
Holding
1,082
New
405
Increased
619
Reduced
41
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$17.4M |
| 2 |
Apple
AAPL
|
+$7.52M |
| 3 |
Broadcom
AVGO
|
+$6.81M |
| 4 |
Bausch Health
BHC
|
+$5.93M |
| 5 |
NBIS
Nebius Group N.V.
NBIS
|
+$4.82M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$2.86M |
| 2 |
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
|
+$1.98M |
| 3 |
EGLE
Eagle Bulk Shipping Inc.
EGLE
|
+$1.84M |
| 4 |
ALTR
Altera Corp
ALTR
|
+$1.74M |
| 5 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$1.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.2% |
| 2 | Healthcare | 13.08% |
| 3 | Industrials | 11.83% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
M&T Bank
MTB
$36.2B
| $31K | ﹤0.01% |
+248
| New | +$30.5K |
|
852
Newell Brands
NWL
$2.56B
| $31K | ﹤0.01% |
+760
| New | +$30.5K |
|
853
Revvity
RVTY
$12.8B
| $31K | ﹤0.01% |
+590
| New | +$30.8K |
|
854
Truist Financial
TFC
$64B
| $31K | ﹤0.01% |
+766
| New | +$30.3K |
|
855
Waters Corp
WAT
$39.9B
| $31K | ﹤0.01% |
+238
| New | +$30.9K |
|
856
Weyerhaeuser
WY
$18.4B
| $31K | ﹤0.01% |
+978
| New | +$31.4K |
|
|
TIF
857
DELISTED
Tiffany & Co.
TIF
| $31K | ﹤0.01% |
+339
| New | +$30.3K |
|
|
ARG
858
DELISTED
Airgas Inc
ARG
| $31K | ﹤0.01% |
+290
| New | +$30.3K |
|
859
Allegion
ALLE
$14.4B
| $30K | ﹤0.01% |
+500
| New | +$30.7K |
|
860
Affiliated Managers Group
AMG
$9.76B
| $30K | ﹤0.01% |
+135
| New | +$30K |
|
861
Aon
AON
$76B
| $30K | ﹤0.01% |
+300
| New | +$30K |
|
862
Ball Corp
BALL
$16.8B
| $30K | ﹤0.01% |
+868
| New | +$31.3K |
|
863
Bread Financial
BFH
$4.38B
| $30K | ﹤0.01% |
+129
| New | +$30.9K |
|
864
CMS Energy
CMS
$22.3B
| $30K | ﹤0.01% |
+936
| New | +$31.4K |
|
865
CVS Health
CVS
$122B
| $30K | ﹤0.01% |
+286
| New | +$29.2K |
|
866
EQT Corp
EQT
$32.3B
| $30K | ﹤0.01% |
+669
| New | +$31.4K |
|
867
Edwards Lifesciences
EW
$51.7B
| $30K | ﹤0.01% |
+1,254
| New | +$28.3K |
|
|
JWN
868
DELISTED
Nordstrom
JWN
| $30K | ﹤0.01% |
+401
| New | +$30.5K |
|
869
Keurig Dr Pepper
KDP
$40.8B
| $30K | ﹤0.01% |
+414
| New | +$31.6K |
|
870
Kimberly-Clark
KMB
$36.5B
| $30K | ﹤0.01% |
+281
| New | +$30.6K |
|
871
Masco
MAS
$15.3B
| $30K | ﹤0.01% |
+1,294
| New | +$30.6K |
|
872
Mohawk Industries
MHK
$9.22B
| $30K | ﹤0.01% |
+156
| New | +$28.9K |
|
873
Navient
NAVI
$853M
| $30K | ﹤0.01% |
+1,664
| New | +$32.6K |
|
874
Nasdaq
NDAQ
$52.9B
| $30K | ﹤0.01% |
+1,827
| New | +$30.7K |
|
875
Public Service Enterprise Group
PEG
$37.7B
| $30K | ﹤0.01% |
+758
| New | +$31.4K |
|
Similar funds
EST
TCM
AWS
WI
JP
VCM
FCB
FCFS
Vident Investment Advisory's Q2 2015 Portfolio in Review
As of Q2 2015, Vident Investment Advisory held 1,082 positions worth $752M, up 51% from $498M the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
Vident Investment Advisory deployed $268M of net new capital in Q2 2015, opening 405 new positions and adding to 619 existing holdings. Its largest new stake was iPath ETNs Linked to the MSCI India Total Return Index: 244,802 shares worth $17.2M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was MALLINCKRODT PUBLIC LIMITED COMPANY, an estimated $2.86M trimmed.
- Vident Investment Advisory's largest Q2 2015 buy was iPath ETNs Linked to the MSCI India Total Return Index: 244,802 shares worth $17.2M.
- Vident Investment Advisory added most to Apple in Q2 2015, an estimated $7.52M increase.
- Vident Investment Advisory's biggest Q2 2015 reduction was MALLINCKRODT PUBLIC LIMITED COMPANY, cutting an estimated $2.86M.
- Vident Investment Advisory fully exited AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q2 2015, selling an estimated $1.98M.
- Vident Investment Advisory's ten largest holdings make up 9.6% of its $752M portfolio in Q2 2015.
- Vident Investment Advisory opened 405 new positions and closed 17 in Q2 2015.
- Vident Investment Advisory's portfolio value rose 51% quarter-over-quarter to $752M.
Based on Vident Investment Advisory's 13F filing for Q2 2015, filed 29 Jul 2015.